Article info

Download PDFPDF
Long-term safety of rituximab in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection

Authors

  1. Correspondence to Dr Dimitrios Vassilopoulos, 2nd Department of Medicine, Hippokration General Hospital, Athens University School of Medicine, 114 Vass. Sophias Ave., Athens 115 27, Greece; dvassilop{at}med.uoa.gr
View Full Text

Citation

Mitroulis I, Hatzara C, Kandili A, et al
Long-term safety of rituximab in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection

Publication history

  • Received May 25, 2012
  • Revised July 27, 2012
  • Accepted August 2, 2012
  • First published August 28, 2012.
Online issue publication 
January 04, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.